The markers worth checking are LDL cholesterol, total cholesterol, apolipoprotein B, lipoprotein(a) and triglycerides. One blood draw covers all five. This page is educational and not medical advice.
Most high cholesterol has an everyday explanation rather than a rare inherited one. Lipid numbers move with how you eat, drink, sleep, train and age, and with the normal hormonal shifts of adult life. None of those drivers produces a sensation you can notice, which is exactly why the condition goes unrecognised for so long.
Several ordinary factors tend to stack up. The most common ones are worth knowing before you look at any number.
Genetics sits underneath all of it. Familial hypercholesterolemia is an inherited condition in which LDL cholesterol is elevated from birth, and research suggests it is more common in the general population than was once assumed, at roughly 1 in 300 people 1. Variants affecting LDL receptor function, apolipoprotein B and PCSK9 account for most identified cases 2. What matters for this page is that the inherited form is just as quiet as the lifestyle driven form, while the exposure starts decades earlier.
Because the condition is silent, blood markers do the work that symptoms cannot. A standard lipid panel reports total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides, and two further markers, apolipoprotein B and lipoprotein(a), add detail that a standard panel can miss.
| Marker | Why it matters here | What a result can and cannot tell you |
|---|---|---|
| LDL cholesterol | Measures the cholesterol carried inside the particles that accumulate in artery walls over years | Shows how much cholesterol is being carried, not how many particles are carrying it, and not whether plaque is present |
| Cholesterol, total | A sum of the cholesterol across all lipoprotein fractions, used in most screening and risk tools | Flags a broad problem, but a high figure can come from high HDL as easily as from high LDL |
| Apolipoprotein B | Counts the atherogenic particles themselves, because each one carries a single apoB molecule | Gives a particle count, but does not identify the cause or separate inherited from everyday drivers |
| Lipoprotein (a) | A largely inherited particle that standard panels do not report and whose cholesterol is counted inside measured LDL | One measurement usually reflects a lifelong level, so it says little about current diet or training |
| Triglycerides | Reflects fat circulating from recent meals, alcohol intake and insulin handling | Very sensitive to the previous 24 to 72 hours, so a single high value may reflect the day before the draw |
Typical lab reference ranges for adults are shown below so you can orient yourself on a report.
| Marker | Typical lab reference range |
|---|---|
| Cholesterol, total | Below 200 mg/dL commonly reported as desirable |
| LDL cholesterol | Below 100 mg/dL commonly reported as optimal |
| Triglycerides (fasting) | Below 150 mg/dL commonly reported as normal |
| Apolipoprotein B | Roughly below 90 to 100 mg/dL on many lab reports |
| Lipoprotein (a) | Often reported as below 30 mg/dL, or below about 75 nmol/L |
These are typical lab reference ranges, and they vary by lab, age and sex. They are reporting thresholds rather than diagnostic cut-offs, and a clinician reads them alongside your history rather than in isolation.
No, LDL cholesterol produces no sensation at any level. That is the single most important thing to understand about it. LDL particles cross into the artery wall, some are retained there, and the slow build of plaque happens without pain, pressure, fatigue or any other warning the body can send you. For many people the first noticeable event is a cardiovascular one, decades after the numbers first drifted.
Visible signs do exist, but they belong to the extreme end. Studies indicate that tendon xanthomas, yellowish deposits on the eyelids and a pale ring around the cornea before age 45 appear in heterozygous familial hypercholesterolemia and are used as supporting physical findings when clinicians assess it 3. Research suggests that, in homozygous familial hypercholesterolemia, which is far rarer and more severe, skin and tendon xanthomas can appear in childhood 4. Seeing any of these is a reason to book an appointment, not a reason to conclude anything on your own. You can read what the number measures on the LDL Cholesterol page.
Several things other than diet move LDL. Weight change in either direction shifts it. Thyroid function, kidney function and pregnancy all influence it. Acute illness or infection can temporarily lower cholesterol, so a result drawn during a flu week may read lower than your usual level. Fasting status, on the other hand, barely affects LDL.
Not on its own, because total cholesterol is a sum rather than a single substance. It combines the cholesterol in LDL particles, in HDL particles and a portion attributed to triglyceride rich particles. A person with a high total cholesterol driven mostly by high HDL is in a different position from a person with the same total driven by high LDL, and the two cannot be separated without the full breakdown.
The number still earns its place. It is the figure most screening programmes start with, it appears in long running risk calculators, and clinical criteria for heterozygous familial hypercholesterolemia combine cholesterol levels with family history and physical findings. Treat it as the headline and the rest of the panel as the article. The Cholesterol - Total page explains what the figure contains.
Other things change it too. Pregnancy raises it substantially. Acute illness lowers it. Ordinary biological variation means two draws a month apart can differ without anything meaningful having happened, which is one reason clinicians look at trends rather than single values.
Because apoB counts particles, and particle number is what contacts the artery wall. Every atherogenic lipoprotein, including LDL, VLDL, IDL and lipoprotein(a), carries exactly one apoB molecule. Measuring apoB therefore gives a direct count of those particles rather than an estimate of the cholesterol they happen to be carrying.
This matters when the two numbers disagree. Two people can share an identical LDL cholesterol while one carries far more, smaller, cholesterol poor particles than the other. That mismatch turns up most often in people with high triglycerides or insulin resistance, where LDL cholesterol can look reassuring while the particle count is not. Apolipoprotein B also sits at the centre of the inherited picture, since variants affecting apolipoprotein B are one of the gene routes behind familial hypercholesterolemia 2. The Apolipoprotein B page covers what the measurement represents.
What else moves apoB is broadly what moves LDL. Weight change, dietary fat intake, thyroid status, pregnancy and alcohol all influence it, and the triglyceride state at the time of the draw affects how the particle population is distributed.
It is usually measured once in a lifetime, because the level is largely set by inheritance and stays fairly stable through adult life. Diet, training and weight loss do very little to it, which is why repeat testing adds little for most people unless a clinician has a specific reason.
There is a practical catch worth knowing. The cholesterol inside lipoprotein(a) particles is counted within your measured LDL cholesterol, so a very high lipoprotein(a) can make LDL look higher than the LDL particles alone would suggest. That overlap is one reason a lipid picture can look inherited when the explanation is more specific. Studies indicate that genetic testing can confirm a familial hypercholesterolemia diagnosis and support cascade screening of close relatives once a variant is identified 5. Whether any of that applies to you is a clinician's call. The Lipoprotein (a) page explains what the particle is.
A few things do nudge the number. Inflammatory states, kidney function and hormonal changes can shift it modestly. Labs also report it in different units, either mg/dL or nmol/L, so comparing two results from different labs without checking units is a common source of confusion.
Yes, but only once levels are very high, which is the exception rather than the rule. Severe elevation can produce eruptive xanthomas, which are small yellowish bumps that appear in crops on the back, buttocks or the backs of the arms and legs. Blood drawn at that level can look milky in the tube. Severe elevation is one of the reasons a clinician may want to review a result promptly, because it can inflame the pancreas.
At more ordinary levels, triglycerides stay silent like the rest of the panel. They are also the most changeable marker on the report. Alcohol in the previous few days, a large or carbohydrate heavy meal before the draw, weight gain, low activity and insulin resistance all move them, and pregnancy raises them as a normal change. That volatility is why one raised triglyceride value is a prompt to repeat the test under standard conditions rather than a conclusion. The Triglycerides page explains what the marker reflects.
A normal lipid panel narrows the question, it does not close it. Several things sit outside what these five numbers can show.
The honest summary is that the panel tells you about exposure, not about damage, and symptoms tell you almost nothing at all.
Call emergency services immediately for chest pain or pressure, pain spreading to the arm, neck or jaw, sudden breathlessness, sudden weakness on one side, a drooping face or difficulty speaking. These are emergencies in their own right, whatever your cholesterol numbers say, and they are not something to assess at home.
Arrange a prompt appointment, within days rather than months, for any of the following.
None of these findings confirms anything by itself, and none of them should be self-diagnosed. A result outside the standard range is worth discussing with a clinician promptly, and it should never be ignored. Discuss your results and any treatment with a clinician or licensed provider.
If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.
All five markers come from a single blood draw. The FitScript Essential panel includes the lipid markers described on this page, and FitScript members have 150+ biomarkers tested per year, which means lipids are read alongside metabolic, hormonal and inflammatory markers rather than in isolation.
Atlas, the AI health advisor, explains what each result shows in plain language and how it compares to previous draws, so you arrive at a consultation understanding your own numbers. Any decision about next steps belongs to a licensed clinician who reviews the full picture, and treatment decisions belong to a licensed provider.
For related reading on what happens after a result, see how do cholesterol lowering medications work.
For most people there are none. Cholesterol can sit well above target for years without producing pain, fatigue or any noticeable change. At very high levels, physical signs can appear, including firm lumps over tendons, yellowish plaques on the eyelids and a pale ring around the cornea in someone under 45. A blood test is the only reliable check.
The honest answer is that the usual sign is nothing at all, which is why screening exists. The few visible clues belong to extreme or inherited elevations rather than ordinary ones, and they involve cholesterol deposits in skin, tendons and the eye. If you notice any of them, book an appointment with a clinician rather than drawing your own conclusion.
No. Cholesterol circulating in the blood does not create a sensation, and the slow narrowing of arteries happens without any warning signal. People often assume they would feel unwell if something were wrong, and that assumption is the main reason elevated numbers go unchecked for decades.
Tiredness and headaches are not features of raised cholesterol itself. If you are experiencing them, the explanation usually lies elsewhere, such as sleep, stress, iron status, thyroid function or blood sugar handling. A broader blood panel and a conversation with a clinician will narrow the list far better than guessing.
Xanthelasma describes soft yellowish plaques that form on or around the eyelids. They can accompany markedly elevated cholesterol, but they also occur in people whose lipid numbers come back normal. Because the two do not always travel together, the appropriate next step is a lipid panel and a clinical assessment, not self-diagnosis.
That depends on your age, family history, previous results and overall risk, so the interval is set by a clinician rather than a fixed rule. People with a strong family history of early heart disease are generally checked earlier and more regularly than people without one. If you have never had a lipid panel, that is the place to start.
Many labs now accept a non-fasting sample for a standard lipid panel, because LDL and total cholesterol change very little with meals. Triglycerides are the exception and rise after eating and after alcohol. Follow whatever instructions your lab or clinician gives you, and keep conditions consistent between draws so results stay comparable.
LDL cholesterol measures how much cholesterol is being carried inside LDL particles. Apolipoprotein B counts the particles themselves, since each atherogenic particle carries one apoB molecule. The two usually agree, but they can diverge, particularly when triglycerides are high, and a clinician decides which one better reflects your situation.